Martin Marietta Materials (MLM)
NYSEMaterialsBuilding MaterialsSnapshot 2026-07-07
$594.23-1.83%
Close 2026-07-07 · 1-day change
Reading MLM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MLM free→NYSEMaterialsBuilding MaterialsSnapshot 2026-07-07
Reading MLM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MLM free→QuarterlyIQ Insights · MLM
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $594.23. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $594 the market pays 32× p/e — above the 24× p/e peer median but in line with its own 31× history. That premium reflects a durable franchise our peer-anchored $551 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $556–$739. Note: our $551 fair value sits below the entire analyst range ($556–$739). Even valued only for durable growth at sustainable margins, it's worth about $681 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $652.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $705.12 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $684.73 | — | — | Hist. CAGR | high |
| graham number | 12M | $281.50 | — | — | TTM | high |
| Peer EV/EBITDA |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$556.00 – $739.00 (median $690.00) · 7 analysts · as of 2026-06-02
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 97% over what the business is worth with no growth; closing that gap needs roughly 8.5 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $16.53/sh owner earnings.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $376.11 |
| 14.3 |
| 32.30 |
| TTM |
| high |
| Peer P/FCF | 12M | $549.34 | 32.1 | 17.12 | TTM | high |
| Peer P/E | 12M | $442.63 | 23.5 | 18.83 | TTM | high |
| Peer P/S | 12M | $220.50 | 2.1 | 105.15 | TTM | high |
| PEG | 12M | $494.34 | 26.3 | 18.83 | TTM | high |
| residual income | 12M | $197.11 | — | — | TTM | high |
| Own P/E history | 12M | $581.36 | 30.9 | 18.83 | TTM | high |
| triangulated | 12M | $443.78 | 23.5 | 18.88 | Triangulated | high |
| Peer P/FCF | 3Y | $835.48 | 32.1 | 26.04 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $651.52 | 23.5 | 27.72 | Analyst | medium |
| Peer P/S | 3Y | $318.71 | 2.1 | 151.98 | guidance | medium |
| PEG | 3Y | $727.62 | 26.3 | 27.72 | Analyst | medium |
| Own P/E history | 3Y | $855.71 | 30.9 | 27.72 | Analyst | medium |
| Peer P/FCF | 5Y | $1104.92 | 32.1 | 34.43 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $828.07 | 23.5 | 35.23 | Analyst | high |
| Peer P/S | 5Y | $405.07 | 2.1 | 193.16 | guidance | high |
| PEG | 5Y | $924.80 | 26.3 | 35.23 | Analyst | high |
| Own P/E history | 5Y | $1087.60 | 30.9 | 35.23 | Analyst | high |